 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TriSalus Life Sciences Inc., (TriSalus or the Company), an oncology company integrating its novel delivery technology with immunotherapy to transform treatment for patients with liver and pancreatic tumors, today announced the completion of its previously announced merger with MedTech Acquisition...

TriSalus Life Sciences Completes Merger with MedTech Acquisition Corporation

TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The firm is also involved in developing an innovative organ-specific platform that prevents optimal delivery and performance of immunotherapeutics in difficult-to-treat diseases. The company is headquartered in Westminster, CO.

Watchers	168
52-Wk Low	$4.57
52-Wk High	$16.24

Market Cap	$133.56M
Volume (M)	4,488.00
52-Wk High	$16.24
52-Wk Low	$4.57

TLSI TriSalus Life Sciences Inc

About

Feed

News

Sentiment

Fundamentals